DLK-1 as a marker to distinguish unrestricted somatic stem cells and mesenchymal stromal cells in cord blood

Stem Cells and Development

Volumn 19, Issue 10, 2010, Pages 1471-1483

  Kluth, Simone Maria ^a   Buchheiser, Anja ^a   Houben, Amelie Pia ^a   Geyh, Stefanie ^a   Krenz, Thomas ^a   Radke, Teja Falk ^a   Wiek, Constanze ^a   Hanenberg, Helmut ^a,b   Reinecke, Petra ^a   Wernet, Peter ^a   Kögler, Gesine ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIBODY; CD45 ANTIGEN;

ADHERENT CELL; ADIPOCYTE; ADIPOGENESIS; ARTICLE; BONE MARROW; CELL CLONING; CELL DIFFERENTIATION; CELL LINEAGE; CELL POPULATION; CELL PROLIFERATION; CHONDROGENESIS; CONTROLLED STUDY; GENE EXPRESSION; GERM LAYER; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; SOMATIC CELL; STROMA CELL; UMBILICAL CORD BLOOD;

BIOLOGICAL MARKERS; CELL DIFFERENTIATION; FETAL BLOOD; GENE EXPRESSION REGULATION; GENE SILENCING; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MESENCHYMAL STEM CELLS; STEM CELLS; STROMAL CELLS;

EID: 77956512282     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2010.0070     Document Type: Article

References (62)

1. Eapen M, P Rubinstein, MJ Zhang, C Stevens, J Kurtzberg, A Scaradavou, FR Loberiza, RE Champlin, JP Klein, MM Horowitz and JE Wagner. (2007). Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet 369:1947-1954.
2. Gluckman E and V Rocha; EBMT Paediatric, Acute Leukemia Working Parties; Eurocord. (2008). Indications and results of cord blood transplant in children with leukemia. Bone Marrow Transplant 41(SUPPL. 2):S80-S82.
3. Rocha V and E Gluckman. (2007). Outcomes of transplantation in children with acute leukaemia. Lancet 369:1906-1908.
4. Kögler G., S Sensken, JA Airey, T Trapp, M Müschen, N Feldhahn, S Liedtke, RV Sorg, J Fischer, C Rosenbaum, S Greschat, A Knipper, J Bender, O Degistirici, J Gao, AI Caplan, EJ Colletti, G Almeida-Porada, HW Müller, E Zanjani and P Wernet. (2004). A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med 200:123-135.
5. Chan SL, M Choi, S Wnendt, M Kraus, E Teng, HF Leong, and S Merchav. (2007). Enhanced in vivo homing of uncultured and selectively amplified cord blood CD34+ cells by cotransplantation with cord blood-derived unrestricted somatic stem cells. Stem Cells 25:529-536.
6. Chang YJ, DT Shih, CP Tseng, TB Hsieh, DC Lee and SM Hwang. (2006). Disparate mesenchyme-lineage tendencies in mesenchymal stem cells from human bone marrow and umbilical cord blood. Stem Cells 24:679-685.
7. Kern S, H Eichler, J Stoeve, H Klüter and K Bieback. (2006). Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24:1294-1301.
8. Kim BO, H Tian, K Prasongsukarn, J Wu, D Angoulvant, S Wnendt, A Muhs, D Spitkovsky and RK Li. (2005). Cell transplantation improves ventricular function after a myocardial infarction: a preclinical study of human unrestricted somatic stem cells in a porcine model. Circulation 112:196-104.
9. Kögler G., P Critser, T Trapp and M Yoder. (2009). Future of cord blood for non-oncology uses. Bone Marrow Transplant 44:683-697
10. van den Berk LC, BJ Jansen, KG Siebers-Vermeulen, MG Netea, T Latuhihin, S Bergevoet, RA Raymakers, G Kogler, CC Figdor, GJ Adema and R Torensma. (2009). Toll-like receptor triggering in cord blood mesenchymal stem cells. J Cell Mol Med 13:3415-3426.
11. Winter M, XN Wang, W Daubener, A Eyking, M Rae, AM Dickinson, P Wernet, G Kogler and RV Sorg. (2008). Suppression of cellular immunity by cord blood-derived unrestricted somatic stem cells is cytokine dependent. J Cell Mol Med 13:2465-2475.
12. Jansen BJ, C Gilissen, H Roelofs, A Schaap-Oziemlak, J Veltman, RA Raymakers, J Jansen, G Kogler, CG Figdor, R Torensma and GJ Adema. (2009). Functional differences between mesenchymal stem cell populations are reflected by their transcriptome. Stem Cells Dev, 19:481-490.
13. Greschat S, J Schira, P Küry, C Rosenbaum, MA de Souza Silva, G Kögler, P Wernet and HW Müller. (2008). Unrestricted somatic stem cells from human umbilical cord blood can be differentiated into neurons with a dopaminergic phenotype. Stem Cells Dev 17:221-232.
14. Kogler G, S Sensken and P Wernet. (2006). Comparative generation and characterization of pluripotent unrestricted somatic stem cells with mesenchymal stem cells from human cord blood. Exp Hematol 34:1589-1595.
15. Sensken S, S Waclawczyk, AS Knaupp, T Trapp, J Enczmann, P Wernet and G Kogler. (2007). In vitro differentiation of human cord blood-derived unrestricted somatic stem cells towards an endodermal pathway. Cytotherapy 9:362-378.
16. Trapp T, G Kögler, A El-Khattouti, RV Sorg, M Besselmann, M Föcking, CP Bührle, I Trompeter, JC Fischer and P Wernet. (2008). Hepatocyte growth factor/c-MET axis-mediated tropism of cord blood-derived unrestricted somatic stem cells for neuronal injury. J Biol Chem 283:32244-32253.
17. Kögler G., TF Radke, A Lefort, S Sensken, J Fischer, RV Sorg and P Wernet. (2005). Cytokine production and hematopoiesis supporting activity of cord blood-derived unrestricted somatic stem cells. Exp Hematol 33:573-583.
18. Hill AJ, I Zwart, HH Tarn, J Chan, C Navarrete, LS Jen and R Navarrete. (2009). Human umbilical cord blood-derived mesenchymal stem cells do not differentiate into neural cell types or integrate into the retina after intravitreal grafting in neonatal rats. Stem Cells Dev 18:399-409.
19. Laborda J, EA Sausville, T Hoffman and V Notario. (1993). dlk, a putative mammalian homeotic gene differentially expressed in small cell lung carcinoma and neuroendocrine tumor cell line. J Biol Chem 268:3817-3820.
20. Smas CM and HS Sul. (1993). Pref-1, a protein containing EGF-like repeats, inhibits adipocyte differentiation. Cell 73:725-734.
21. Smas CM, L Chen and HS Sul. (1997). Cleavage of membrane-associated pref-1 generates a soluble inhibitor of adipocyte differentiation. Mol Cell Biol 17:977-988.
22. Floridon C, CH Jensen, P Thorsen, O Nielsen, L Sunde, JG Westergaard, SG Thomsen and B Teisner. (2000). Does fetal antigen 1 (FA1) identify cells with regenerative, endocrine and neuroendocrine potentials? A study of FA1 in embryonic, fetal, and placental tissue and in maternal circulation. Differentiation 66:49-59.
23. Gregoire FM, CM Smas and HS Sul. (1998). Understanding adipocyte differentiation. Physiol Rev 78:783-809.
24. Abdallah BM, CH Jensen, G Gutierrez, RG Leslie, TG Jensen and M Kassem. (2004). Regulation of human skeletal stem cells differentiation by Dlkl/Pref-1. J Bone Miner Res 19:841-852.
25. Moon YS, CM Smas, K Lee, JA Villena, KH Kim, EJ Yun and HS Sul. (2002). Mice lacking paternally expressed Pref-1/Dlkl display growth retardation and accelerated adiposity. Mol Cell Biol 22:5585-5592.
26. Tanimizu N, M Nishikawa, H Saito, T Tsujimura and A Miyajima. (2003). Isolation of hepatoblasts based on the expression of Dlk/Pref-1. J Cell Sci 116(PART 9):1775-1786.
27. Anisimov SV, KV Tarasov, D Tweedie, MD Stern, AM Wobus and KR Boheler. (2002). SAGE identification of gene transcripts with profiles unique to pluripotent mouse R1 embryonic stem cells. Genomics 79:169-176.
28. Moore KA, B Pytowski, L Witte, D Hicklin and IR Lemischka. (1997). Hematopoietic activity of a stromal cell transmembrane protein containing epidermal growth factor-like repeat motifs. Proc Natl Acad Sci USA 94:4011-4016.
29. Radke TF, A Buchheiser, A Lefort, M Maleki, P Wernet and G Kogler. (2007). GMP-conform generation and cultivation of unrestricted somatic stem cells (USSC) from cord blood using the SEPAX-separation method and a closed culture system applying cell stacks. Blood 110:367
30. Liedtke S, J Enczmann, S Waclawczyk, P Wernet and G Kogler. (2007). Oct4 and its pseudogenes confuse stem cell research. Cell Stem Cell 1:364-366.
31. Liedtke S, M Stephan and G Kögler. (2008). Oct4 expression revisited: potential pitfalls for data misinterpretation in stem cell research. Biol Chem 389:845-850.
32. Takahashi K, K Tanabe, M Ohnuki, M Narita, T Ichisaka, K Tomoda and S Yamanaka. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861-872.
33. Greenberg AS, JJ Egan, SA Wek, NB Garty, EJ Blanchette-Mackie and C Londos. (1991). Perilipin, a major hormonally regulated adipocyte-specific phosphoprotein associated with the periphery of lipid storage droplets. J Biol Chem 266:11341-11346.
34. Bianco P and PG Robey. (2001). Stem cells in tissue engineering. Nature 414:118-121.
35. Caplan AI. (2009). Why are MSCs therapeutic? New data: new insight. J Pathol 217:318-324.
36. Pittenger MF, AM Mackay, SC Beck, RK Jaiswal, R Douglas, JD Mosca, MA Moorman, DW Simonetti, S Craig and DR Marshak. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147
37. Prockop DJ. (1997). Marrow stromal cells as stem cells for non-hematopoietic tissues. Science 276:71-74.
38. da Silva Meirelles L, AI Caplan and NB Nardi. (2008). In search of the in vivo identity of mesenchymal stem cells. Stem Cells 26:2287-2299.
39. Takashima Y, T Era, K Nakao, S Kondo, M Kasuga, AG Smith and S Nishikawa. (2007). Neuroepithelial cells supply an initial transient wave of MSC differentiation. Cell 129:1377-1388.
40. Dennis JE and P Charbord. (2002). Origin and differentiation of human and murine stroma. Stem Cells 20:205-214.
41. Crisan M, S Yap, L Casteilla, CW Chen, M Corselli, TS Park, G Andriolo, B Sun, B Zheng, L Zhang, C Norotte, PN Teng, J Traas, R Schugar, BM Deasy, S Badylak, HJ Buhring, JP Giacobino, L Lazzari, J Huard and B Peault. (2008). A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3:301-313.
42. Manca MF, I Zwart, J Beo, R Palasingham, LS Jen, R Navarrete, J Girdlestone and CV Navarrete. (2008). Characterization of mesenchymal stromal cells derived from full-term umbilical cord blood. Cytotherapy 10:54-68.
43. Smas CM and HS Sul. (1997). Molecular mechanisms of adipocyte differentiation and inhibitory action of pref-1. Crit Rev Eukaryot Gene Expr 7:281-298.
44. Kim KA, JH Kim, Y Wang and HS Sul. (2007). Pref-1 (preadipo-cyte factor 1) activates the MEK/extracellular signal-regulated kinase pathway to inhibit adipocyte differentiation. Mol Cell Biol 27:2294-2308.
45. Lee K, JA Villena, YS Moon, KH Kim, S Lee, C Kang and HS Sul. (2003). Inhibition of adipogenesis and development of glucose intolerance by soluble preadipocyte factor-1 (Pref-1). J Clin Invest 111:453-461.
46. Samulewicz SJ, A Seitz, L Clark and E Heber-Katz. (2002). Expression of preadipocyte factor-l(Pref-l), a delta-like protein, in healing mouse ears. Wound Repair Regen 10:215-221.
47. Yevtodiyenko A and JV Schmidt. (2006). Dlk1 expression marks developing endothelium and sites of branching morphogenesis in the mouse embryo and placenta. Dev Dyn 235:1115-1123.
48. Li L, SJ Forman and R Bhatia. (2005). Expression of DLK1 in hematopoietic cells results in inhibition of differentiation and proliferation. Oncogene 24:4472-4476.
49. Jensen CH, B Teisner, P Højrup, HB Rasmussen, OD Madsen, B Nielsen and K Skjødt. (1993). Studies on the isolation, structural analysis and tissue localization of fetal antigen 1 and its relation to a human adrenal-specific cDNA, pG2. Hum Reprod 8:635-641.
50. Larsen JB, CH Jensen, HD Schroder, B Teisner, P Bjerre and C Hagen. (1996). Fetal antigen 1 and growth hormone in pituitary somatotroph cells. Lancet 347:191.
51. White JD, T Vuocolo, M McDonagh, MD Grounds, GS Harper, NE Cockett and R Tellam. (2008). Analysis of the callipyge phenotype through skeletal muscle development; association of Dlkl with muscle precursor cells. Differentiation 76:283-298.
52. Waclawczyk S, S Geyh, M Kluth, U Floegel, A Buchheiser and G Kögler. (2009). Hepatic differentiation of unrestricted somatic stem cells (USSC). Hum Gene Ther 20:1400-1401.
53. Liedtke S, A Buchheiser, J Bosch, F Bosse, F Kruse, X Zhao, S Santourlidis and G Kögler. (2010). The HOX code as a "biological fingerprint" to distinguish functionally distinct stem cell populations derived from cord blood. Stem Cell Res 5:40-50.
54. Charbord P, M Tavian, L Humeau and B Péault. (1996). Early ontogeny of the human marrow from long bones: an immunohistochemical study of hematopoiesis and its microen-vironment. Blood 87:4109-4119.
55. Wang Y and HS Sul. (2009). Pref-1 regulates mesenchymal cell commitment and differentiation through Sox9. Cell Metab 9:287-302.
56. Gimble JM, CE Robinson, X Wu and KA Kelly. (1996). The function of adipocytes in the bone marrow stroma: an update. Bone 19:421-428.
57. Baladrón V., MJ Ruiz-Hidalgo, ML Nueda, MJ Díaz-Guerra, JJ García-Ramírez, E Bonvini, E Gubina and J Laborda. (2005). dlk acts as a negative regulator of Notchl activation through interactions with specific EGF-like repeats. Exp Cell Res 303:343-359.
58. Garcés C., MJ Ruiz-Hidalgo, J Font de Mora, C Park, L Miele, J Goldstein, E Bonvini, A Porrás and J Laborda. (1997). Notch-1 controls the expression of fatty acid-activated transcription factors and is required for adipogenesis. J Biol Chem 272:29729-29734.
59. Micchelli CA, EJ Rulifson and SS Blair. (1997). The function and regulation of cut expression on the wing margin of Drosophila: Notch, Wingless and a dominant negative role for Delta and Serrate. Development 124:1485-1495.
60. de Celis JF and SJ Bray. (2000). The Abruptex domain of Notch regulates negative interactions between Notch, its ligands and Fringe. Development 127:1291-1302.
61. Bray SJ, S Takada, E Harrison, SC Shen, and AC Ferguson-Smith. (2008). The atypical mammalian ligand Delta-like homologue 1 (Dlk1) can regulate Notch signalling in Drosophila. BMC Dev Biol 8:11.
62. Tanimizu N and A Miyajima. (2004). Notch signaling controls hepatoblast differentiation by altering the expression of liver-enriched transcription factors. J Cell Sci 117(PART 15):3165-3174.